ALLMedicine™ Respiratory Syncytial Virus Infection Center
Research & Reviews 425 results
https://doi.org/10.1093/infdis/jiac248
The Journal of Infectious Diseases; Gómez-Carballa A, Pischedda S et. al.
Jun 18th, 2022 - CD14 and related genes in respiratory morbidity after Respiratory Syncytial Virus infection.|2022|Gómez-Carballa A,Pischedda S,Rivero-Calle I,Montoto-Louzao J,Martinón-Torres F,|
https://doi.org/10.1007/s12016-022-08948-8 10.1067/s0022-3476(03)00510-9 10.1016/S0140-6736(17)30938-8 10.1067/s0022-3476(03)00511-0 10.1097/01.inf.0000136869.21397.6b 10.1007/s12016-013-8368-9 10.1007/s40121-014-0046-6 10.1016/j.vaccine.2017.05.045 10.1093/infdis/jiz390 10.2217/fmb-2016-0106 10.1093/infdis/jiu316 10.1016/s0022-3476(81)80829-3 10.1016/j.jcv.2017.08.017 10.1093/oxfordjournals.aje.a115826 10.1136/adc.2002.017780 10.1093/infdis/134.3.211 10.1016/s0264-410x(03)00355-4 10.1002/jmv.1890070403 10.1016/j.jaci.2008.10.043 10.1097/INF.0b013e31815ac585 10.1371/journal.pone.0166706 10.1542/peds.109.2.210 10.1016/j.jpeds.2008.07.053 10.1371/journal.pone.0069390 10.3389/fimmu.2019.00548 10.1002/jmv.1890090210 10.1016/0264-410x(95)00222-m 10.1084/jem.20020781 10.1128/jcm.24.5.894-898.1986
Clinical Reviews in Allergy & Immunology; Abu-Raya B, Reicherz F et. al.
Jun 12th, 2022 - The highest morbidity and mortality from respiratory syncytial virus (RSV) infection occurs in young infants. Immunization of expectant mothers during pregnancy has the potential to substantially reduce the burden of RSV disease in a majority of i...
https://doi.org/10.3390/ijerph19116941
International Journal of Environmental Research and Publi... Ae R, Shibata Y et. al.
Jun 11th, 2022 - The study tested the hypothesis that human mobility may be a potential factor affecting reductions in droplet-transmissible pediatric infectious diseases (PIDs) during the coronavirus disease-2019 (COVID-19) pandemic mitigation period in 2020. An ...
https://doi.org/10.1371/journal.pone.0269043
PloS One; Kubota J, Takahashi S et. al.
May 28th, 2022 - In infants, respiratory syncytial virus (RSV) infection occasionally causes severe symptoms requiring respiratory support; however, supportive care is the primary treatment. This study compared the use of respiratory support among infants with RSV...
https://clinicaltrials.gov/ct2/show/NCT03656510
May 16th, 2022 - JNJ-53718678 is an investigational respiratory syncytial virus (RSV) specific fusion inhibitor and is under development for the treatment of RSV infection, which results in an upper and/or lower respiratory tract illness. The primary hypothesis of...
Guidelines 1 results
https://doi.org/10.1542/peds.2014-1665
Pediatrics ,
Jul 30th, 2014 - Palivizumab was licensed in June 1998 by the Food and Drug Administration for the reduction of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV) in children at increased risk of severe disease. Since that time, ...
Clinicaltrials.gov 12 results
https://clinicaltrials.gov/ct2/show/NCT03656510
May 16th, 2022 - JNJ-53718678 is an investigational respiratory syncytial virus (RSV) specific fusion inhibitor and is under development for the treatment of RSV infection, which results in an upper and/or lower respiratory tract illness. The primary hypothesis of...
https://clinicaltrials.gov/ct2/show/NCT04752644
Apr 1st, 2022 - A Phase 2a, Randomised, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Immunogenicity and Efficacy of the Recombinant MVA-BN®-RSV Vaccine against Respiratory Syncytial Virus Infection in the Virus Challenge Model in Healthy Adult P...
https://clinicaltrials.gov/ct2/show/NCT03334695
Jul 23rd, 2021 - The purpose of this study is to assess a trend for the prophylactic efficacy of a single dose of 1*10^11 virus particles (vp) of adenovirus serotype 26 respiratory syncytial virus pre-fusion F protein (Ad26.RSV.preF) administered intramuscularly t...
https://clinicaltrials.gov/ct2/show/NCT03332459
Apr 13th, 2021 - RSV is a leading cause of lower respiratory tract disease in infants. The primary hypothesis is that treatment of RSV-infected infants/children with lumicitabine (also known as JNJ-64041575 or ALS-008176) will decrease subsequent wheezing/asthma c...
https://clinicaltrials.gov/ct2/show/NCT04531735
Aug 28th, 2020 - This single center cross-sectional study was conducted in University of Health Sciences Dr Behçet Uz Children's Hospital with a 400-bed tertiary care hospital in İzmir, Turkey, during the period of March 11 - April 30, 2020. This hospital is a ped...
News 25 results
https://www.staging.medscape.com/viewarticle/927518
Mar 26th, 2020 - For children exposed to acid-suppressant medications, such as proton pump inhibitors and histamine 2 receptor antagonists, during their first year of life, the risk for recurrent wheeze at age 3 is significantly elevated, researchers warn. "We are...
https://www.mdedge.com/familymedicine/article/206884/pulmonary-infections/fuo-pneumonia-often-distinguishes-influenza-rsv?channel=39313
MDedge Infectious Disease; Bruce Jancin
Aug 22nd, 2019 - LJUBLJANA, SLOVENIA – Fever of unknown origin and pneumonia are two clinical features useful in distinguishing between influenza and respiratory syncytial virus infection as the cause of hospitalization in infants and young children, Cihan Papan,.
https://www.mdedge.com/infectiousdisease/article/206884/pulmonary-infections/fuo-pneumonia-often-distinguishes-influenza
Bruce Jancin
Aug 22nd, 2019 - LJUBLJANA, SLOVENIA – Fever of unknown origin and pneumonia are two clinical features useful in distinguishing between influenza and respiratory syncytial virus infection as the cause of hospitalization in infants and young children, Cihan Papan,.
https://www.mdedge.com/chestphysician/article/150645/lung-cancer/video-rapid-influenza-test-obviates-empiric-antivirals
Mitchel L. Zoler, PhD, MDedge News
Oct 31st, 2017 - TORONTO – A test that only requires a maximum 2-hour wait for results was highly accurate at detecting influenza and respiratory syncytial virus infection in lung transplant patients, according to research presented at the CHEST annual meeting on.
https://www.medscape.com/viewarticle/886314
Oct 10th, 2017 - Hypertonic Versus Normal Saline Nebulizer Treatments The goal of a recent study[1] was to evaluate whether nebulized hypertonic saline (3%) was more beneficial than nebulized normal saline (0.9%) in the treatment of infants presenting to the emerg...
